UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of 725.25 million as of February 12, 2026. Its market cap has increased by 94.05% in one year.

Market Cap

725.25M

Enterprise Value

727.11M

Revenue

71.80M

Ranking

n/a

PE Ratio

n/a

Stock Price

20.85

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from 129.71M to 725.25M, an increase of 459.15%. That is a compound annual growth rate of 21.65%.

Market Cap History

Date	Market Cap	% Change
Feb 12, 2026	694.46M	-14.74%
Dec 31, 2025	814.52M	126.90%
Dec 31, 2024	358.99M	-1.24%
Dec 29, 2023	363.49M	113.84%
Dec 30, 2022	169.98M	7.95%
Dec 31, 2021	157.47M	-46.00%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
May 4, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BioPharma Credit	773.01M
Trainline	766.15M
MONY Group	765.14M
Domino's Pizza Group	747.19M
Hays plc	736.44M
Close Brothers Group	734.16M
A.G. BARR p.l.c.	730.98M
Chesnara	717.04M

Market Cap Rankings